Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2005
11/10/2005WO2005106024A1 Method and assembly for dna isolation with dry reagents
11/10/2005WO2005106023A1 Pcr process and arrangement for dna amplification using dry reagents
11/10/2005WO2005106022A2 Method of selecting sunflower genotypes with high oleic acid content in seed oil
11/10/2005WO2005106021A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 8 (dpp8)
11/10/2005WO2005106020A1 Method for the prediction of individual disease course in sepsis
11/10/2005WO2005106019A1 Granulin-epithelin precursor (gep) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (hcc)
11/10/2005WO2005106018A1 Direct assay of skin cholesterol in skin samples removed by tape stripping
11/10/2005WO2005106017A2 Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices
11/10/2005WO2005106016A1 METHOD OF DETECTING Th1 CELL
11/10/2005WO2005106015A1 Method of screening remedy for diabetes
11/10/2005WO2005106014A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor adrb1 (adrb1)
11/10/2005WO2005106013A2 Use of mdck cell line to predict corneal penetration of drugs
11/10/2005WO2005106012A2 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
11/10/2005WO2005106002A2 Polyvalent viral vectors and a system for production thereof
11/10/2005WO2005105997A1 Connexin 40 tissue specific gene mutations
11/10/2005WO2005105994A1 Method of disulfide crosslink forming type in vitro protein synthesis
11/10/2005WO2005105987A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 2 (csnk1d iso 2)
11/10/2005WO2005105850A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
11/10/2005WO2005105838A2 Ion channel
11/10/2005WO2005105282A1 Closed reaction vessel system
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005104813A2 Method of identifying hairpin dna probes by partial fold analysis
11/10/2005WO2005104810A2 Novel therapeutic targets in cancer
11/10/2005WO2005104763A2 Improved method for identifying peptides in a biological sample
11/10/2005WO2005098421A3 Sensor for contaminants
11/10/2005WO2005084210A3 Multiplex detection probes
11/10/2005WO2005083441A3 Diagnostic and therapeutics for diseases associated with proto-oncogene tyrosine-protein kinase (fyn)
11/10/2005WO2005083115A3 Method for the identification of sepsis
11/10/2005WO2005083086A3 Epha4 as therapeutic target of prc and pdaca
11/10/2005WO2005078129A3 Thrombosis diagnosis/prognosis method
11/10/2005WO2005076975A3 Complexed polypeptide and adjuvant for improved vaccines
11/10/2005WO2005075665A3 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
11/10/2005WO2005075637A3 Screening assays
11/10/2005WO2005074641A8 Variant neuronal nicotinic alpha-7 receptor and methods of use
11/10/2005WO2005066616A3 Biosensor and method of making
11/10/2005WO2005065693A3 Use of cathepsin z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases
11/10/2005WO2005064018A3 Microwave mediated synthesis of nucleic acid probes
11/10/2005WO2005054272A3 Human immunodeficiency virus entry inhibitor assay
11/10/2005WO2005049860A3 Diagnostic and therapeutic methods and assays
11/10/2005WO2005040418A3 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
11/10/2005WO2005033313A3 Intracelluar trapping of radionuclides by enzyme-mediated reduction
11/10/2005WO2005026374A3 Method for synthesizing nucleic acids, and application thereof
11/10/2005WO2005024058A3 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
11/10/2005WO2005022143B1 Method and apparatus for assay of electrochemical properties
11/10/2005WO2005010203A3 Treatment of cells for fluorescence in situ hybridization
11/10/2005WO2005009222A3 Method of determining sperm capacitation
11/10/2005WO2005003318A3 Assay and process for labeling and detection of micro rna and small interfering rna sequences
11/10/2005WO2005001131A3 Methods for diagnosing mood disorders
11/10/2005WO2004104212A3 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis
11/10/2005WO2004067764A3 Nucleic acid sequencing using nicking agents
11/10/2005WO2004064482A3 Alien sequences
11/10/2005WO2004055495A3 Chip-in-a-well scanning
11/10/2005WO2004050898A3 Ampk pathway components
11/10/2005WO2004048933A3 Methods for diagnosing rcc and other solid tumors
11/10/2005WO2004029283A3 Subtelomeric dna probes and method of producing the same
11/10/2005WO2004020970A3 α-AMYLASE ASSAY AND USES THEREOF
11/10/2005US20050251873 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050251679 Original Transcript System: Method and System to issue, submit and view original electronic transcripts.
11/10/2005US20050251348 Gene-to-gene graphical representation
11/10/2005US20050251346 Method and apparatus for reaction route graphs for reaction mechanism and kinetics modeling
11/10/2005US20050251345 Small molecules and a pharmacophore model for inhibition of anthrax lethal factor
11/10/2005US20050250855 Compounds for treating human papillomavirus
11/10/2005US20050250724 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
11/10/2005US20050250722 FcgammaRIIA-specific nucleic acid interference
11/10/2005US20050250720 Novel compound
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250673 Neurodegenerative disease treatment
11/10/2005US20050250220 Isoelectric particles and uses thereof
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250205 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods
11/10/2005US20050250200 Testing microreactor, testing device and testing method
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250195 Crystallographic structure of TcPRACA and uses therefor
11/10/2005US20050250183 In vivo incorporation of unnatural amino acids
11/10/2005US20050250176 Microorganisms detecting device and method
11/10/2005US20050250175 Bacterial cell wall skeleton component preparaion
11/10/2005US20050250174 administering fungicides to skins of mammals that have been infected with fungi, then analyzing the efficiency by culturing segments of the skin and counting viable cells of microorganisms
11/10/2005US20050250172 Method and device for determination of hydrogen peroxide in body fluid
11/10/2005US20050250171 Culturing cells with fluorophore-labeled protein covalently bound to vessel; high throughput screening of modulators of tumor metastasis or osteoclast differentiation
11/10/2005US20050250170 composition comprising an apo-carbonic anhydrase protein and a photoluminescent molecule selected from 4-(2-hydroxyethylthio)-7-aminosulfonyl-2,1,3-benzoxadiazole and hydroxynaphthalenesulphonamide 2; homogeneous fluorescence polarization (anisotropy) assays; detecting and quantifying ions in solution
11/10/2005US20050250169 solid support; a specific indicator immobilized on the support; a retaining member which holds the support; retaining member and support are configured so the support readily contacts a surface being tested for presence of biological soil; evaluate the efficacy of a cleaning or disinfecting process
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050250166 Cdc7-ask kinase complex, substrates of the kinase complex, antibody specific to the substrate, and method of screening compound capable of inhibiting cdc7-ask kinase using the same
11/10/2005US20050250165 Test piece for measuring high-density lipoprotein (HDL) cholesterol
11/10/2005US20050250161 inducing tolerance to xenograft tissue or organ; tolerogenic antigen presenting cells (APC) which overexpress monocyte inhibitory receptor (MIR); generating antigen specific allospecific human-suppressor CD8+CD28- T cells; detecting expression of ILT3, ILT4, ILT2 protein; autoimmune diseases; host cell
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050250155 Multiple marker characterization of single cells
11/10/2005US20050250154 Peptides associated with hepsin protease active site for use in identification of modulators for treatment of cell proliferative disorders
11/10/2005US20050250151 System, method, and computer software for genotyping analysis and identification of allelic imbalance
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050250149 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
11/10/2005US20050250148 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
11/10/2005US20050250147 Digital profiling of polynucleotide populations
11/10/2005US20050250146 Multiplexed detection of e.g., bacteria, viruses, and biological toxins utilizing two markers for each agent; the presence or absence in a sample of each of the two markers per agent is determined in separate reactions; however each reaction is used to detect a single marker for multiple agents
11/10/2005US20050250145 On-line chemical reaction system
11/10/2005US20050250142 analyzing DNA sequences for alleles on human chromosomes in linkage with polymorphic markers; screening for susceptibility or resistance to viral diseases
11/10/2005US20050250141 Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots
11/10/2005US20050250138 Process for the enumeration and identification of microorganisms
1 ... 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 ... 3003